THERALASE TECHNOLOGIES INC (TLT.CA) Stock Price, Quote, News and Overview
TSX-V:TLT - TSX Venture Exchange - CA88337V1004 - Common Stock - Currency: CAD
TLT.CA Quote, Performance and Key Statistics
TSX-V:TLT (3/7/2025, 7:00:00 PM)
0.25
+0.01 (+2.04%)
The current stock price of TLT.CA is 0.25 CAD. In the past month the price decreased by -3.85%. In the past year, price increased by 21.95%.
TLT.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
| MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
| EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
Related stock screener links
About TLT.CA
Company Profile
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. The company is headquartered in Toronto, Ontario. The company went IPO on 2004-11-02. The firm is engaged in the research and development of light activated compounds and their associated drug formulations. The firm operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The firm develops products both internally and using the assistance of specialist external resources.
Company Info
THERALASE TECHNOLOGIES INC
41 Hollinger Road
TORONTO ONTARIO M4B 3G4 CA
CEO: Shawn Shirazi
Employees: 20
Company Website: https://theralase.com/
Investor Relations: http://theralase.com/about-us/
Phone: 14166995273
THERALASE TECHNOLOGIES INC / TLT.CA FAQ
What is the stock price of THERALASE TECHNOLOGIES INC today?
The current stock price of TLT.CA is 0.25 CAD. The price increased by 2.04% in the last trading session.
What is the ticker symbol for THERALASE TECHNOLOGIES INC stock?
The exchange symbol of THERALASE TECHNOLOGIES INC is TLT and it is listed on the TSX Venture Exchange exchange.
On which exchange is TLT.CA stock listed?
TLT.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for THERALASE TECHNOLOGIES INC stock?
9 analysts have analysed TLT.CA and the average price target is 0.82 CAD. This implies a price increase of 226.4% is expected in the next year compared to the current price of 0.25. Check the THERALASE TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THERALASE TECHNOLOGIES INC worth?
THERALASE TECHNOLOGIES INC (TLT.CA) has a market capitalization of 61.95M CAD. This makes TLT.CA a Micro Cap stock.
How many employees does THERALASE TECHNOLOGIES INC have?
THERALASE TECHNOLOGIES INC (TLT.CA) currently has 20 employees.
What are the support and resistance levels for THERALASE TECHNOLOGIES INC (TLT.CA) stock?
THERALASE TECHNOLOGIES INC (TLT.CA) has a support level at 0.24 and a resistance level at 0.26. Check the full technical report for a detailed analysis of TLT.CA support and resistance levels.
Is THERALASE TECHNOLOGIES INC (TLT.CA) expected to grow?
The Revenue of THERALASE TECHNOLOGIES INC (TLT.CA) is expected to decline by -24.75% in the next year. Check the estimates tab for more information on the TLT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy THERALASE TECHNOLOGIES INC (TLT.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TLT.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TLT.CA, evaluating the profitability, health, valuation and growth aspects
- THERALASE TECHNOLOGIES INC (TLT.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THERALASE TECHNOLOGIES INC (TLT.CA) Sales and EPS estimates to see what analysts future expectations are.
- THERALASE TECHNOLOGIES INC (TLT.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THERALASE TECHNOLOGIES INC (TLT.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- THERALASE TECHNOLOGIES INC (TLT.CA) Stock Chart to make your own analysis
- THERALASE TECHNOLOGIES INC (TLT.CA) Latest news and press-releases to stay up to date.
Does THERALASE TECHNOLOGIES INC (TLT.CA) stock pay dividends?
TLT.CA does not pay a dividend.
When does THERALASE TECHNOLOGIES INC (TLT.CA) report earnings?
THERALASE TECHNOLOGIES INC (TLT.CA) will report earnings on 2025-03-25, after the market close.
What is the Price/Earnings (PE) ratio of THERALASE TECHNOLOGIES INC (TLT.CA)?
THERALASE TECHNOLOGIES INC (TLT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
TLT.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TLT.CA. When comparing the yearly performance of all stocks, TLT.CA is one of the better performing stocks in the market, outperforming 71.44% of all stocks.
TLT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TLT.CA. TLT.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
TLT.CA Financial Highlights
Over the last trailing twelve months TLT.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 8.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -134.35% | ||
| ROE | -202.38% | ||
| Debt/Equity | 0.1 |
TLT.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to TLT.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 66.67% and a revenue growth -24.75% for TLT.CA